Wednesday, May 13, 2026
ScienceAI Generated

Astronomers Confirm New Earth-like Exoplanet, Proxima Centauri d, in Habitable Zone

Astronomers have confirmed the discovery of Proxima Centauri d, a new exoplanet orbiting Proxima Centauri, the closest star to our Sun. This exoplanet is notable for its extremely low mass, making it one of the lightest ever found, and its orbit within the star's habitable zone, sparking renewed interest in the potential for extraterrestrial life.

4 min read1 viewsMay 13, 2026
Share:

New Exoplanet Discovery Ignites Search for Life Beyond Earth

GENEVA, SWITZERLAND – In a landmark announcement that has captivated the scientific community, astronomers have confirmed the discovery of Proxima Centauri d, a new exoplanet orbiting Proxima Centauri, the closest star to our Sun. This groundbreaking finding, detailed in the journal Astronomy & Astrophysics, adds a third known planet to the Proxima Centauri system and has significant implications for the ongoing search for life beyond Earth.

Proxima Centauri d is particularly intriguing due to its incredibly low mass, estimated to be at least 0.26 Earth masses, making it one of the lightest exoplanets ever detected. Its orbital period is a mere 5.1 days, placing it within the habitable zone of its parent star, Proxima Centauri. While its proximity to the star suggests it might be too hot for liquid water on its surface, the concept of a 'habitable zone' is dynamic and depends on various atmospheric conditions. The discovery was made using the European Southern Observatory’s (ESO) Very Large Telescope (VLT) in Chile, employing the radial velocity method, which detects tiny wobbles in a star’s movement caused by the gravitational pull of orbiting planets.

Unveiling the 'Third Signal'

The initial hints of Proxima Centauri d emerged from observations with the ESPRESSO instrument on the VLT. João Faria, a researcher at the Instituto de Astrofísica e Ciências do Espaço, Portugal, and lead author of the study, described the painstaking process of isolating the signal. Researchers had been observing Proxima Centauri for years, primarily to confirm Proxima Centauri b, a planet discovered in 2016. During these observations, a faint, five-day signal began to appear, which could not be attributed to Proxima Centauri b or the more distant Proxima Centauri c. This persistent, subtle wobble in the star's motion ultimately led to the confirmation of Proxima Centauri d.

The team's meticulous work involved filtering out various sources of noise, including the star's own magnetic activity, to confidently identify the planetary signal. The precision of the ESPRESSO instrument was crucial, allowing astronomers to detect changes in the star's velocity as small as 40 centimeters per second. This level of accuracy highlights the remarkable advancements in exoplanet detection technology over the past two decades.

Implications for Habitability and Future Research

While Proxima Centauri d's orbit is closer to its star than Mercury is to our Sun, Proxima Centauri itself is a red dwarf, much cooler and smaller than our Sun. This means that its habitable zone is much closer in. The planet receives roughly the same amount of radiation as Mercury does from our Sun, which could make it too hot to sustain liquid water. However, the exact conditions on Proxima Centauri d remain unknown, and future studies will aim to characterize its atmosphere, if it has one, and assess its potential for habitability. The existence of multiple planets in this nearby system, including Proxima Centauri b which is also within the habitable zone, makes it a prime target for follow-up observations with next-generation telescopes like the James Webb Space Telescope.

This discovery underscores the incredible diversity of planetary systems in our galaxy and reinforces the idea that planets, even small ones, are common. The proximity of Proxima Centauri makes its planetary system an ideal laboratory for studying exoplanet formation, evolution, and the potential for life beyond our solar system. As technology continues to advance, astronomers hope to directly image these distant worlds and uncover more of their secrets. The official announcement and further details can be found on the European Southern Observatory's website: ESO.org.

The Ongoing Quest for Exoplanets

The detection of Proxima Centauri d adds to a growing catalog of thousands of confirmed exoplanets. Each new discovery refines our understanding of planetary science and brings us closer to answering one of humanity's most profound questions: Are we alone in the universe? The Proxima Centauri system, just over four light-years away, continues to be a focal point in this exciting quest, promising further revelations as observational capabilities improve.


For more information, visit the official website.

#Exoplanet#Proxima Centauri#Habitable Zone#Astronomy#Space Exploration

Related Articles

A new CRISPR startup is betting regulators will ease up on gene-editing© Technologyreview
Science

CRISPR Breakthrough: In Vivo Gene Editing Shows Sustained Benefits for Genetic Blood Disorders

New clinical trial results published in Nature demonstrate significant and sustained therapeutic benefits of in-vivo CRISPR gene editing for patients with specific inherited genetic disorders, marking a pivotal moment for the technology. The study, involving patients with transfusion-dependent beta-thalassemia and severe sickle cell disease, utilized a novel CRISPR-based therapy, exagamglogene autotemcel (exa-cel), showing durable improvements and moving closer to broader FDA approval for such applications.

5h ago1
CRISPR Gene Editing Shows Sustained Success in Sickle Cell and Beta-Thalassemia Trials — science news© AI Generated
Science

CRISPR Gene Editing Shows Sustained Success in Sickle Cell and Beta-Thalassemia Trials

Recent late-stage human clinical trials utilizing CRISPR-Cas9 gene editing have demonstrated significant and sustained therapeutic benefits for patients with severe genetic blood disorders. Patients suffering from sickle cell disease and transfusion-dependent beta-thalassemia have achieved remarkable symptom remission, marking a pivotal moment in genetic medicine. These advancements highlight the potential of CRISPR to offer functional cures for previously intractable conditions.

9h ago1
CRISPR Gene Editing Shows Promising Results in Human Trials for Genetic Disorders — science news© AI Generated
Science

CRISPR Gene Editing Shows Promising Results in Human Trials for Genetic Disorders

Recent clinical trial data has highlighted significant advancements in CRISPR-based therapies, particularly for inherited blood disorders. Patients treated for sickle cell disease and beta-thalassemia have shown sustained improvements, bringing these innovative treatments closer to regulatory approval and broader clinical use.

21h ago1
The Rarest of All Diseases Are Becoming Treatable© Theatlantic
Science

CRISPR Therapies Show Significant Promise in Treating Sickle Cell and Beta-Thalassemia

Recent clinical trials have demonstrated significant progress in using CRISPR-based gene editing to treat inherited genetic disorders like sickle cell disease and beta-thalassemia. New data presented highlights the efficacy and safety of these groundbreaking therapies, offering hope for patients with limited treatment options.

1d ago1